Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Exmceuticals Inc
C.EXM
Healthcare
EXMceuticals Inc. is a bio-sciences company that is focused on the production of cannabinoid formulations. The Company operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:EXM)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
OU812Protocol
X
View Profile
View Bullboard History
Post by
OU812Protocol
on Aug 10, 2022 10:43am
What's going on folks..?
Hello...anybody out there? How long is this EXM Cease Trade going to last? I just read abt the combined venture with Global Canna...and then....? Any updates would make this shareholder feel a little
...more
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Post by
Luckierjack2
on Jan 11, 2021 5:24am
Cease traded
Didn't file financials on time. Cmon guys. Get it together
(22)
•••
UVPGuy
X
View Profile
View Bullboard History
Post by
UVPGuy
on Nov 05, 2020 12:47pm
EXMceuticals is poised to sail through Portugal's gateway
This morning, BNN Bloomberg posted an article on EXMceuticals Inc. (CSE: EXM | FSE: A2PAW2 | OTCQB: EXM) and their new venture in Portugal. They are focused on tapping into the European market
...more
(3)
•••
Battuta29
X
View Profile
View Bullboard History
Comment by
Battuta29
on Oct 17, 2019 8:33pm
RE:P.E. ratio of 0.5?
there's no good news coming from one of their key assets I'm told. No chance imo the forecasts hold water. Value is dated.
(0)
•••
fieldreporter
X
View Profile
View Bullboard History
Post by
fieldreporter
on Apr 03, 2019 8:20am
P.E. ratio of 0.5?
Their website has a presentation that forecasts CAD$75m profit next year. $13m this year. arket cap CAD$50m? doesn't look right.
(0)
•••
fieldreporter
X
View Profile
View Bullboard History
Post by
fieldreporter
on Jan 31, 2019 7:48am
EXM Ceuticals
Is this being re-listed today as EXM Ceuticals, the medical cannabis company?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday